<DOC>
	<DOCNO>NCT02187562</DOCNO>
	<brief_summary>The objective study investigate influence meloxicam low dose aspirin induced inhibition platelet aggregation thromboxane B2 , meloxicam give aspirin .</brief_summary>
	<brief_title>Effect Steady State Meloxicam Low Dose Aspirin Induced Inhibition Platelet Aggregation Thromboxane Synthesis Healthy Males Females</brief_title>
	<detailed_description />
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<criteria>Healthy male female subject determine result screen Signed write informed consent accordance Good Clinical Practice ( GCP ) local legislation Age &gt; =18 &lt; = 60 year The Body Mass Index ( BMI ) ≥ 18.5 kg/m2 ( square meter ) ≤ 29.9 kg/m2 . Laboratory value within clinical normal range Any finding medical examination ( include blood pressure , pulse rate electrocardiogram ( ECG ) ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Surgery gastrointestinal tract ( except appendectomy ) Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder History orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( &gt; 24 hour ) ( &lt; 1 month prior administration trial ) Use drug , might influence result trial , particular aspirin contain drug ( &lt; 14 day prior administration trial ) Participation another trial investigational drug ( &lt; 1 month prior administration ( least 10 time relevant elimination halflife ) trial ) Having prescription medication 2 week prior study drug administration counter medication 1 week prior study drug administration ( least 10 time relevant elimination halflife ) Smoker ( &gt; 10 cigarette 3 cigar 3 pipes/day ) Inability refrain smoke trial day Alcohol abuse ( &gt; 60 gram ( g ) /day ) Drug abuse Blood donation loss &gt; 400 mL ( &lt; 1 month prior administration trial ) Excessive physical activity ( &lt; 5 day prior administration trial ) Any ECG value outside reference range clinical relevance include , limited QTcB &gt; 480 m QRS interval &gt; 110 ms History familial bleeding disorder History haemorrhagic diatheses History gastrointestinal ulcer , perforation bleed History bronchial asthma Inability comply dietary regimen study centre Inability comply investigator 's instruction For female subject : Pregnancy Positive pregnancy test No adequate contraception ( e.g . sterilisation , intrauterine device ( IUP ) , oral contraceptive ) Inability maintain adequate contraception whole study period Lactation period Ovarian hormone substitution oral contraception continue study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>